DOW
58
-5
UAL
56
2
FMC
40
4
IFF
56
-3
HON
47
-12
UPS
55
-6
PNW
66
3
GME
63
12
LB
38
-7
FE
55
5
MAT
51
-3
SWN
77
4
A
44
-2
ADI
59
-2
KEY
51
-3
VZ
47
2
LH
48
-2
INTC
43
6
XRX
52
-3
CNX
80
4
DOW
58
-5
UAL
56
2
FMC
40
4
IFF
56
-3
HON
47
-12
UPS
55
-6
PNW
66
3
GME
63
12
LB
38
-7
FE
55
5
MAT
51
-3
SWN
77
4
A
44
-2
ADI
59
-2
KEY
51
-3
VZ
47
2
LH
48
-2
INTC
43
6
XRX
52
-3
CNX
80
4
Financhill
Back

Range Cancer Therapeutics ETF Stock Predictions

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.
Sell
44

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.50
Seasonality Move:
-2.75%

7 Day Trial

ALL ACCESS PASS

$ 7

10 minutes on Tuesday - $1,270 by Friday?

Click here to discover how this "odd" trade could double your money each week.

Range Cancer Therapeutics ETF Stock Forecast

  • Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically fallen by 1.3% based on the past 8 years of stock performance.
  • Range Cancer Therapeutics ETF has fallen lower in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Range Cancer Therapeutics ETF Stock Undervalued?
    The current Range Cancer Therapeutics ETF [CNCR] share price is $15.69. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Range Cancer Therapeutics ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically fallen by 1.3% based on the past 8 years of stock performance.

Range Cancer Therapeutics ETF Stock Rating

Sell
44
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF overpriced?

  • Range Cancer Therapeutics ETF has fallen lower in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Range Cancer Therapeutics ETF Stock Price History

Is CNCR stock going to rise?

  • The current trend is moderately bullish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
17.96
52-Week Low:
9.22

Prediction Charts

Market Cap:
0
Price in USD:
15.69
Volume:
6.01K
Beta:
1.12

Technical Analysis

SMA50:
14.87
SMA100:
14.69
SMA200:
14.75
52-Wk Change:
40.59%

Stock Predictions

  • Is Range Cancer Therapeutics ETF stock public?
    Yes, Range Cancer Therapeutics ETF is a publicly traded company.
  • What is the Range Cancer Therapeutics ETF stock quote today?
    The Range Cancer Therapeutics ETF stock price is 15.69 USD today.
  • How to buy Range Cancer Therapeutics ETF stock online?
    You can buy Range Cancer Therapeutics ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-3 14.88 14.53 15.08 14.39
Sep-4 14.44 14.49 14.49 14.44
Sep-5 14.42 14.47 14.47 14.42
Sep-6 14.57 14.18 14.57 13.94
Sep-9 14.79 14.96 14.96 14.74
Sep-10 14.94 15.23 15.23 14.82
Sep-11 15.05 15.21 15.31 15.01
Sep-12 15.23 15.45 15.57 15.23
Sep-13 15.88 16.11 16.11 15.87
Sep-16 16.27 15.85 16.27 15.80
Sep-17 15.83 15.65 15.99 15.65
Sep-18 15.64 15.40 15.72 15.40
Sep-19 15.77 15.77 15.88 15.77
Sep-20 15.58 15.69 15.72 15.55

Range Cancer Therapeutics ETF Earnings

Data Unavailable

Range Cancer Therapeutics ETF Forecast Revenue Growth

Data Unavailable

* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.